Market Overview 2025-2033
Saudi Arabia medical tourism market size reached USD 1,341.1 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 7,918.6 Million by 2033, exhibiting a growth rate (CAGR) of 21.80% during 2025-2033. The market is expanding due to rising demand for cost-effective treatments, advanced healthcare infrastructure, and strategic government initiatives. Growth is driven by Vision 2030, international accreditations, and integrated wellness offerings. With evolving patient preferences, the industry is becoming more dynamic, accessible, and globally competitive.
Key Market Highlights:
✔️ Strong market growth driven by rising investments in healthcare infrastructure and specialized treatments
✔️ Increasing influx of international patients seeking cost-effective, high-quality medical services
✔️ Expanding government initiatives promoting Saudi Arabia as a regional hub for medical tourism
Request for a sample copy of the report: https://www.imarcgroup.com/saudi-arabia-medical-tourism-market/requestsample
Saudi Arabia Medical Tourism Market Trends and Drivers:
The Saudi Arabia medical tourism market is experiencing rapid growth, driven by major investments in healthcare infrastructure and digital innovation. As part of the Vision 2030 initiative, the Saudi government has allocated over $10 billion to develop advanced medical cities and diversify healthcare services. Flagship projects such as the King Faisal Specialist Hospital & Research Centre in Riyadh and Johns Hopkins Aramco Healthcare in Dhahran are establishing the Kingdom as a hub for specialized care in oncology, cardiology, and orthopedics. These facilities are attracting patients from across the Gulf Cooperation Council (GCC) countries, Africa, and Asia.
In 2024, the launch of the NEOM Health Sector marked a significant milestone. This futuristic medical hub integrates robotic surgery, AI-driven diagnostics, and precision medicine, positioning Saudi Arabia at the forefront of healthcare innovation. The government’s push for international credibility has also led to over 40 hospitals pursuing Joint Commission International (JCI) accreditation. As a result, medical visa applications have increased by 22% annually, highlighting the country’s rising appeal as a destination for affordable, high-quality care—particularly for uninsured patients from Europe and North America.
To further streamline access, the Ministry of Health introduced the “Virtual Medical Tourism Platform” in 2024. This digital service enables international patients to consult with specialists online, compare treatment packages, and secure e-visas within 72 hours. It has reduced pre-arrival planning time by 35%. Additionally, hospitals like King Abdullah Medical City have adopted blockchain for secure health records and AI for patient triage, improving efficiency and care delivery. Demand for tele-rehabilitation, including virtual reality-based physiotherapy, is also increasing—particularly among Middle Eastern patients requiring post-operative care. These advancements support the country’s Smart Health strategy, which aims to digitize 90% of healthcare services by 2030.
In line with this vision, digital health investments surpassed $2.3 billion in 2024, with a focus on predictive analytics, real-time translation tools, and personalized treatment plans. The Saudi Arabia medical tourism market share is also expanding through regulatory reforms and strategic partnerships. In early 2024, the Kingdom launched the GCC Medical Tourism Visa, offering multi-entry access for up to 18 months to patients from Bahrain, Kuwait, Oman, Qatar, and the UAE—an increase of 300% compared to previous policies. Simultaneously, the Saudi Commission for Health Specialties (SCFHS) simplified licensing processes for foreign medical professionals, enabling hospitals to attract talent from Europe and North America.
Collaborations with global insurers such as Allianz and Bupa have further enhanced accessibility by increasing coverage for elective procedures, reducing out-of-pocket expenses for international patients by as much as 40%. A notable development includes a $500 million joint venture between the Ministry of Investment and Cleveland Clinic Abu Dhabi to establish a hybrid care facility in Jeddah, reinforcing Saudi Arabia’s ambitions to become a leading referral center in the region. As a result of these initiatives, medical tourism revenue rose by 17% in 2024, reaching $1.2 billion. High-demand services include cosmetic surgery, fertility treatments, and chronic disease management.
The Saudi medical tourism sector is undergoing a transformation from a regional alternative to a global competitor. This evolution is supported by a patient-centered approach and luxury-focused offerings. In 2024, many hospitals introduced bundled care packages that combine complex procedures—such as robotic-assisted knee replacements—with recovery stays at Red Sea resorts, leading to a 28% rise in long-stay patients. Sustainability is also gaining prominence. Riyadh’s Sultan Bin Abdulaziz Humanitarian City became carbon-neutral, implementing solar-powered operations and zero-waste surgical protocols.
Despite this progress, the market faces rising competition from regional players. The UAE continues to draw patients with established healthcare corridors, while Egypt appeals with cost-effective dental and cosmetic treatments. In response, Saudi Arabia is investing in niche specialties such as gene therapy for rare diseases and gender-specific wellness retreats. The Kingdom is also leveraging its religious tourism sector by offering health screenings to over 2 million Umrah pilgrims annually.
With these advancements and Vision 2030 targets in sight, the Saudi Arabia medical tourism market size is expected to surpass $3.8 billion in annual revenue by 2027. This growth will reshape global perceptions of healthcare quality and accessibility in the Kingdom, reinforcing its emerging role as a premier destination for international medical travel.
Saudi Arabia Medical Tourism Market Segmentation:
The report segments the market based on product type, distribution channel, and region:
Study Period:
Base Year: 2024
Historical Year: 2019-2024
Forecast Year: 2025-2033
Breakup by Treatment Type:
- Cosmetic Treatment
- Dental Treatment
- Cardiovascular Treatment
- Orthopedic Treatment
- Bariatric Surgery
- Fertility Treatment
- Ophthalmic Treatment
- Others
Breakup by Service Provider:
- Public
- Private
Breakup by Region:
- Northern and Central Region
- Western Region
- Eastern Region
- Southern Region
Competitive Landscape:
The market research report offers an in-depth analysis of the competitive landscape, covering market structure, key player positioning, top winning strategies, a competitive dashboard, and a company evaluation quadrant. Additionally, detailed profiles of all major companies are included.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
